NAGE Stock Summary and Trading Ideas (Niagen Bioscience | NASDAQ:NAGE)

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Niagen Bioscience trades on the NASDAQ stock market under the symbol NAGE.

As of September 25, 2026, NAGE stock price climbed to $3.05 with 596,777 million shares trading.

NAGE has a beta of 0.56, meaning it tends to be less sensitive to market movements. NAGE has a correlation of 0.02 to the broad based SPY ETF.

NAGE has a market cap of $242.92 million. This is considered a Small Cap stock.

Last quarter Niagen Bioscience reported $30 million in Revenue and $.01 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.01.

The top ETF exchange traded funds that NAGE belongs to (by Net Assets): VTI, IWM, VXF, VDC, IWO.

NAGE has underperformed the market in the last year with a price return of -67.6% while the SPY ETF gained +18.4%. NAGE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.9% and +0.3%, respectively, while the SPY returned +5.3% and +1.2%, respectively.

NAGE support price is $2.95 and resistance is $3.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NAGE shares will trade within this expected range on the day.